Nadia Iovieno, MD

JCP
Rapidity of Improvement With Intranasal Esketamine for MDD
Meta-Analysis

December 12, 2022

This meta-analysis found that augmenting antidepressants with intranasal esketamine vs placebo was more effective in reducing depression severity at 24 hours and study endpoint.
Rebecca S. Hock, Anna Feeney, Nadia Iovieno, et al
JCP
Meta-Analysis

June 15, 2021

Prior meta-analyses have found vortioxetine to be efficacious for depression. Building on those findings, the present meta-analysis examined the effect that placebo response has on drug-placebo effect size in...
Nadia Iovieno, George I. Papakostas, Anna Feeney, et al
JCP
Original Research

July 25, 2017

Cognitive deficits are common in depression, but studies suggest that cognitive dysfunction is difficult to treat with antidepressants. Can adding an atypical antipsychotic medication to antidepressant treatment help lessen...
Nadia Iovieno, Richard C. Shelton, Samuel R. Petrie, et al
JCP
Meta-Analysis

May 25, 2016

Is one drug good enough? Read this review of 215 double-blind, randomized, placebo-controlled trials to discover which monotherapies have overall short-term efficacy in treating MDD and bipolar depression.
George I. Papakostas, Max A. Martinson, Maurizio Fava, et al
JCP
Review Article

February 3, 2015

George I. Papakostas, Søren D. Østergaard, Nadia Iovieno
JCP
Original Research

July 15, 2013

Cristina Cusin, Nadia Iovieno, Dan V. Iosifescu, et al
JCP
Review Article

October 15, 2012

Nadia Iovieno, George I. Papakostas
JCP
Review Article

April 3, 2012

Nadia Iovieno, George I. Papakostas
JCP
Article

December 15, 2011

Enrico Tedeschini, Yeciel Levkovitz, Nadia Iovieno, et al
JCP
ASCP Corner

August 15, 2011

Martin Desseilles, Janet Witte, Trina E. Chang, et al
JCP
Article

April 19, 2011

Nadia Iovieno, Enrico Tedeschini, Kate H. Bentley, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe